Table 1 Cytology and mutation data of the 195 LBC samples.

From: Identification of cancer driver mutations in liquid-based cytology samples for the screening of endometrial diseases

Category of diagnosis

Histological classification (number of cases)

Cytology

Genetic analysis

  

Malignant or suspicious

Negative

Driver mutation (+)

Driver mutation (−)

Primary endometrial malignancy (n = 39)

Endometrial carcinoma

    

 Endometrioid carcinoma (33)

20

13

25

8

 Carcinosarcoma (2)

2

0

2

0

 Clear cell carcinoma (2)

1

1

1

1

 Mucinous carcinoma (1)

1

0

1

0

Endometrial sarcoma

    

 Low-grade endometrial stromal sarcoma (1)

0

1

0

1

Non-endometrial malignancy (n = 15)

Cervical cancer (8)

6

2

5

3

Ovarian cancer (6)

2

4

1

5

Metastatic cancer (1)

1

0

1

0

Premalignant disease (n = 16)

Endometrial hyperplasia (9)

0

9

6

3

Endometrial polyp(s) (7)

0

7

2

5

Benign/no disease (n = 125)

Myoma uteri/adenomyosis (66)

0

66

17

49

CIN (11)

0

11

4

7

Benign ovarian tumour (13)

0

13

3

10

No disease (35)

0

35

8

27

Total (n = 195)

33

162

76

119